Rohini Prashar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rohini Prashar has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Antu Segal
Henry Ford Health, Transplant Institute, Detroit, USA
2 shared publications - Kendyll Gartrelle
Henry Ford Health, Transplant Institute, Detroit, USA
2 shared publications - Lauren Malinzak
Henry Ford Health, Transplant Institute, Detroit, USA
2 shared publications - Michelle T. Jesse
Henry Ford Health, Transplant Institute, Detroit, USA
2 shared publications - Shunji Nagai
Division of Transplant Surgery, Henry Ford Hospital, Detroit, USA
2 shared publications Zara Sragi
Henry Ford Health, Transplant Institute, Detroit, USA
2 shared publications
Latest Publications
- Open Access
- 14 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1792-1806
A Pre-Kidney Transplant Blood-Based Next-Generation Sequencing Assay to Predict Early Acute Rejection
Key Points: Pretransplant early acute rejection risk stratification offers a novel approach to personalized immunosuppression management in patients who received a kidney transplant. Stratifying immunologic risk independent of donor characteristics may help guide immunosuppression management in patients who received a kidney transplant. The pretransplant risk assessment gene set reflects metabolic and immune pathways involved in T-cell– and antibody-mediated mechanisms of transplant rejection. Background: Although donor and recipient characteristics are used to estimate graft failure risk, they remain limited in predicting early acute rejection (EAR). We developed and validated a next-generation sequencing assay targeting the pretransplant immunologic profile to predict EAR following kidney transplantation. Methods: This prospective, international study enrolled 321 kidney transplant participants across 13 sites, forming discovery and validation cohorts. Peripheral blood was collected before transplant and at 1, 3, 6, 12, and 24 months post-transplant, with protocol biopsies performed at 3 and 12 months, as well as any indication biopsies. Biopsies were assessed by a blinded central pathologist according to the 2019 Banff criteria. The pretransplant risk assessment (PTRA) test to evaluate RNA expression of a 29-gene signature algorithm designed to predict EAR risk was clinically validated using 122 deceased donor kidney transplant recipients. Results: PTRA classified 31 of 122 participants (25%) as high risk and 91 (75%) as low risk. There were nine EAR events in the first 60 days post-transplant: 6/31 (19%) in the high-risk group and 3/91 (3%) in the low-risk group. PTRA discrimination for EAR at 60 days post-transplant yielded an area under the curve of 0.78 (95% confidence interval [CI], 64.4 to 91.5), P < 0.001. A cutoff of ≤45 was defined as low risk and >45 as high risk for EAR within 60 days post-transplant. Sensitivity was 0.67 (95% CI, 0.36 to 0.97), specificity 0.78 (95% CI, 0.70 to 0.86), positive predictive value 0.19 (95% CI, 0.05 to 0.33), and negative predictive value 0.97 (95% CI, 0.93 to 1.00). The odds ratio comparing patients identified as high versus low risk by PTRA was 7.04 (95% CI, 1.64 to 30.2), P = 0.009. Conclusions: This study validates the ability of PTRA to stratify kidney transplant recipients as high or low risk for EAR using a pretransplant transcriptomic profile, with implications for graft health and personalized treatment management.
- 14 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1792-1806
Open AccessA Pre-Kidney Transplant Blood-Based Next-Generation Sequencing Assay to Predict Early Acute Rejection
Key Points: Pretransplant early acute rejection risk stratification offers a novel approach to personalized immunosuppression management in patients who received a kidney transplant. Stratifying immunologic risk independent of donor characteristics may help guide immunosuppression management in patients who received a kidney transplant. The pretransplant risk assessment gene set reflects metabolic and immune pathways involved in T-cell– and antibody-mediated mechanisms of transplant rejection. Background: Although donor and recipient characteristics are used to estimate graft failure risk, they remain limited in predicting early acute rejection (EAR). We developed and validated a next-generation sequencing assay targeting the pretransplant immunologic profile to predict EAR following kidney transplantation. Methods: This prospective, international study enrolled 321 kidney transplant participants across 13 sites, forming discovery and validation cohorts. Peripheral blood was collected before transplant and at 1, 3, 6, 12, and 24 months post-transplant, with protocol biopsies performed at 3 and 12 months, as well as any indication biopsies. Biopsies were assessed by a blinded central pathologist according to the 2019 Banff criteria. The pretransplant risk assessment (PTRA) test to evaluate RNA expression of a 29-gene signature algorithm designed to predict EAR risk was clinically validated using 122 deceased donor kidney transplant recipients. Results: PTRA classified 31 of 122 participants (25%) as high risk and 91 (75%) as low risk. There were nine EAR events in the first 60 days post-transplant: 6/31 (19%) in the high-risk group and 3/91 (3%) in the low-risk group. PTRA discrimination for EAR at 60 days post-transplant yielded an area under the curve of 0.78 (95% confidence interval [CI], 64.4 to 91.5), P < 0.001. A cutoff of ≤45 was defined as low risk and >45 as high risk for EAR within 60 days post-transplant. Sensitivity was 0.67 (95% CI, 0.36 to 0.97), specificity 0.78 (95% CI, 0.70 to 0.86), positive predictive value 0.19 (95% CI, 0.05 to 0.33), and negative predictive value 0.97 (95% CI, 0.93 to 1.00). The odds ratio comparing patients identified as high versus low risk by PTRA was 7.04 (95% CI, 1.64 to 30.2), P = 0.009. Conclusions: This study validates the ability of PTRA to stratify kidney transplant recipients as high or low risk for EAR using a pretransplant transcriptomic profile, with implications for graft health and personalized treatment management.
- Open Access
- 3 March 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (6) , 1376-1389
Longitudinal Changes in the Impact of Socioeconomic Status on Graft Failure in Kidney Transplantation
Key Points: Employment status and insurance type consistently affected graft survival in KT, whereas the influence of education level varied over time post-transplant. The area deprivation index was linked to graft failure in KT from the early to the long-term post-transplantation period. Follow-up strategies to optimize long-term KT outcomes should address socioeconomic factors at both individual and area levels. Background: Socioeconomic status is recognized as a factor influencing graft survival in adult kidney transplantation (KT). However, limited research has examined whether socioeconomic factors influence transplant outcomes differently across post-transplantation periods. We evaluated the longitudinal impact of socioeconomic factors on graft failure post-KT over time. Methods: Adult KT alone performed from 2003 to 2013 were evaluated using the Organ Procurement and Transplantation Network database. The period of post-transplantation was divided into three categories, and the outcome of each group is as follows; group 1: graft failure within 1 year in all patients, group 2: graft failure within 5 years in 1-year graft survivors, and group 3: graft failure within 10 years in 5-year graft survivors. We explored the influence of socioeconomic factors on outcomes in living donor kidney transplantation (LDKT) and deceased donor kidney transplantation (DDKT), separately. Socioeconomic factors included patient education level, employment status at transplantation, insurance status, and area deprivation index (ADI). Higher ADI scores represent greater socioeconomic deprivation. Results: In total, 153,660 adult KT were performed from 2003 to 2013 (group 1), of which 140,699 recipients survived at 1 year (group 2) and 106,238 recipients survived at 5 years (group 3) post-transplantation. While employment status and insurance status consistently influenced graft failure over time, the impact of education level was time-dependent. High school education was associated with a high risk of graft failure, compared with post-college education only in the later post-transplantation periods (group 3) for both DDKT (hazard ratio, 1.09; P = 0.025) and LDKT (hazard ratio, 1.26; P < 0.001), but not in the early period (group 1). ADI-based analysis showed that recipients from highly deprived areas had worse post-transplantation outcomes across all periods in both DDKT and LDKT. Conclusions: The impact of individual-level socioeconomic factors on post-KT outcomes varied over time. Socioeconomically disadvantaged patients had an increased risk of graft failure from the early to the long-term post-KT period. To optimize long-term outcomes, follow-up strategies should incorporate both individual-level and area-level socioeconomic factors.
- 3 March 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (6) , 1376-1389
Open AccessLongitudinal Changes in the Impact of Socioeconomic Status on Graft Failure in Kidney Transplantation
Key Points: Employment status and insurance type consistently affected graft survival in KT, whereas the influence of education level varied over time post-transplant. The area deprivation index was linked to graft failure in KT from the early to the long-term post-transplantation period. Follow-up strategies to optimize long-term KT outcomes should address socioeconomic factors at both individual and area levels. Background: Socioeconomic status is recognized as a factor influencing graft survival in adult kidney transplantation (KT). However, limited research has examined whether socioeconomic factors influence transplant outcomes differently across post-transplantation periods. We evaluated the longitudinal impact of socioeconomic factors on graft failure post-KT over time. Methods: Adult KT alone performed from 2003 to 2013 were evaluated using the Organ Procurement and Transplantation Network database. The period of post-transplantation was divided into three categories, and the outcome of each group is as follows; group 1: graft failure within 1 year in all patients, group 2: graft failure within 5 years in 1-year graft survivors, and group 3: graft failure within 10 years in 5-year graft survivors. We explored the influence of socioeconomic factors on outcomes in living donor kidney transplantation (LDKT) and deceased donor kidney transplantation (DDKT), separately. Socioeconomic factors included patient education level, employment status at transplantation, insurance status, and area deprivation index (ADI). Higher ADI scores represent greater socioeconomic deprivation. Results: In total, 153,660 adult KT were performed from 2003 to 2013 (group 1), of which 140,699 recipients survived at 1 year (group 2) and 106,238 recipients survived at 5 years (group 3) post-transplantation. While employment status and insurance status consistently influenced graft failure over time, the impact of education level was time-dependent. High school education was associated with a high risk of graft failure, compared with post-college education only in the later post-transplantation periods (group 3) for both DDKT (hazard ratio, 1.09; P = 0.025) and LDKT (hazard ratio, 1.26; P < 0.001), but not in the early period (group 1). ADI-based analysis showed that recipients from highly deprived areas had worse post-transplantation outcomes across all periods in both DDKT and LDKT. Conclusions: The impact of individual-level socioeconomic factors on post-KT outcomes varied over time. Socioeconomically disadvantaged patients had an increased risk of graft failure from the early to the long-term post-KT period. To optimize long-term outcomes, follow-up strategies should incorporate both individual-level and area-level socioeconomic factors.
- Open Access
- 26 September 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-9
Correction to: Access to robotic assisted kidney transplant for recipients: a systematic review and call for reporting standards
- 26 September 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-9
Open AccessCorrection to: Access to robotic assisted kidney transplant for recipients: a systematic review and call for reporting standards
- 4 June 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-16
Access to robotic assisted kidney transplant for recipients: a systematic review and call for reporting standards
Robot-assisted kidney transplantation (RAKT) is a relatively novel, minimally invasive option for kidney transplantation. However, clarity on recipient selection in the published literature is lacking thereby significantly limiting interpretation of safety and other outcomes. This systematic review aimed to identify and synthesize the data on selection of RAKT recipients, compare the synthesized data to kidney transplant recipients across the USA, and explore geographical clusters of availability of RAKT. Systematic literature review, in accordance with PRISMA, via OVID MEDLINE, Embase, and Web of science from inception to March 5, 2023. All data entry double blinded and quality via Newcastle Ottawa Scale. 44 full-text articles included, encompassing approximately 2402 kidney transplant recipients at baseline but with considerable suspicion for overlap across publications. There were significant omissions of information across studies on patient selection for RAKT and/or analysis. Overall, the quality of studies was very low. Given suspicion of overlap across studies, it is difficult to determine how many RAKT recipients received living (LD) versus deceased donor (DD) organs, but a rough estimate suggests 89% received LD. While the current RAKT literature provides preliminary evidence on safety, there are significant omissions in reporting on patient selection for RAKT which limits interpretation of findings. Two recommendations: (1) international consensus is needed for reporting guidelines when publishing RAKT data and (2) larger controlled trials consistently reporting recipient characteristics are needed to clearly determine selection, safety, and outcomes across both LD and DD recipients.
- 4 June 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-16
Access to robotic assisted kidney transplant for recipients: a systematic review and call for reporting standards
Robot-assisted kidney transplantation (RAKT) is a relatively novel, minimally invasive option for kidney transplantation. However, clarity on recipient selection in the published literature is lacking thereby significantly limiting interpretation of safety and other outcomes. This systematic review aimed to identify and synthesize the data on selection of RAKT recipients, compare the synthesized data to kidney transplant recipients across the USA, and explore geographical clusters of availability of RAKT. Systematic literature review, in accordance with PRISMA, via OVID MEDLINE, Embase, and Web of science from inception to March 5, 2023. All data entry double blinded and quality via Newcastle Ottawa Scale. 44 full-text articles included, encompassing approximately 2402 kidney transplant recipients at baseline but with considerable suspicion for overlap across publications. There were significant omissions of information across studies on patient selection for RAKT and/or analysis. Overall, the quality of studies was very low. Given suspicion of overlap across studies, it is difficult to determine how many RAKT recipients received living (LD) versus deceased donor (DD) organs, but a rough estimate suggests 89% received LD. While the current RAKT literature provides preliminary evidence on safety, there are significant omissions in reporting on patient selection for RAKT which limits interpretation of findings. Two recommendations: (1) international consensus is needed for reporting guidelines when publishing RAKT data and (2) larger controlled trials consistently reporting recipient characteristics are needed to clearly determine selection, safety, and outcomes across both LD and DD recipients.
- Top Cited PapersOpen Access
- 1 November 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (11) , 3051-3060
Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study
- 1 November 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (11) , 3051-3060
Top Cited PapersOpen AccessClinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study